Company intelligence / Profile preview

Clinion

Austin, Texas, United States

Ownership: Private
Development stage: Other

Overview

Clinion provides a comprehensive, AI-enabled eClinical platform that integrates Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM), Clinical Trial Management System (CTMS), electronic Patient-Reported Outcomes (eCOA), eConsent, Document Automation, and AI Medical Coding. Their solutions are designed to accelerate and streamline clinical trial management for CROs, sponsors, and pharmaceutical/biotech companies, with a focus on efficiency, data quality, and regulatory compliance. The company has received industry recognition for innovation, especially for its integration of AI/ML and generative AI in clinical research software.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Clinion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinion.

Explore the full profile